Chinese SinoVac Biotech Ltd. (Nasdaq: SVA) shares have been frozen since 2019 amid shareholder disputes when market cap was ...

The Trump administration is ending U.S. support for immunizations abroad because of its opposition not only to foreign aid, ...

A Sinovac Biotech Ltd. minority investor fighting for a $600 million dividend and board changes at the vaccine company is ...

IN CONTRAST, the Reconstituted Imposter Former Board Slate is responsible for the very issues they now claim they’ll resolve. Their unlawful actions triggered the 2019 NASDAQ trading halt and forced ...

Retail investors own 30% of the US market, but only cast corporate ballots at the same rate. With big stockholders split on ...

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program.

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1 ®, which has supplied the Chinese government's vaccination campaign and stockpiling program.

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program.

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program.